Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

[1]  S. Pileri,et al.  Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas , 2021, Cells.

[2]  M. Z. Cader,et al.  Targeted RNA sequencing enhances gene expression profiling of ultra-low input samples , 2020, RNA biology.

[3]  W. Klapper,et al.  Experience with provisional WHO‐entities large B‐cell lymphoma with IRF4‐rearrangement and Burkitt‐like lymphoma with 11q aberration in paediatric patients of the NHL‐BFM group , 2020, British journal of haematology.

[4]  A. López-Guillermo,et al.  IRF4-rearranged Large B-cell lymphoma (LBCL) has a genomic profile distinct to other LBCL in children and young adults. , 2019, Blood.

[5]  A. Rosenwald,et al.  Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  E. Domany,et al.  mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues , 2018, BMC Genomics.

[7]  L. Pasqualucci,et al.  Genetics of diffuse large B-cell lymphoma. , 2018, Blood.

[8]  Stefano Monti,et al.  Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes , 2018, Nature Medicine.

[9]  Roland Schmitz,et al.  Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma , 2018, The New England journal of medicine.

[10]  A. Rosenwald,et al.  Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium , 2017, Haematologica.

[11]  A. Younes,et al.  High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma. , 2017, Blood reviews.

[12]  M. Czuczman,et al.  ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection? , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[13]  N. Shinton.  WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[14]  A. Ng,et al.  Diffuse large B-cell lymphoma. , 2007, Seminars in radiation oncology.

[15]  Meland,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[16]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[17]  J. Higginson.  International Agency for Research on Cancer. , 1968, WHO chronicle.